Cytek Biosciences Reports First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cytek Biosciences, Inc. (CTKB) Misses Q1 EPS by 7c
May 9, 2023 4:44 PM EDTCytek Biosciences, Inc. (NASDAQ: CTKB) reported Q1 EPS of ($0.05), $0.07 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $37.1 million versus the consensus estimate of $47.17 million.
GUIDANCE:
Cytek Biosciences, Inc. sees FY2023 revenue of $205-220 million, versus the... More



